Larvol Delta - 23andMe-Announces-Presentation-of-Phase-1-Clinical-Data-for-23ME00610-an-Investigational-Antibody-Targeting-CD200R1-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2023

23ME-00610 - 23andMe

https://www.globenewswire.com/news-release/2023/03/14/2627209/0/en/23andMe-Announces-Presentation-of-Phase-1-Clinical-Data-for-23ME-00610-an-Investigational-Antibody-Targeting-CD200R1-at-the-American-Association-for-Cancer-Research-AACR-Annual-Mee.html

Mar 14, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next